Berman Capital Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$42K Buy
340
+309
+997% +$36.7K 0.01% 743
2021
Q2
$3K Sell
31
-2
-6% -$269 ﹤0.01% 1486
2021
Q1
$4K Buy
33
+30
+1,000% +$4.53K ﹤0.01% 1333
2020
Q4
$0 Buy
+3
New +$345 ﹤0.01% 1725

Other funds holding GH

Berman Capital Advisors's GH Position: Q3 2021 in Review

Berman Capital Advisors increased its Guardant Health (GH) stake by 997% in Q3 2021, buying an estimated $36.7K and bringing the position to 340 shares worth $42K. The position accounts for 0.01% of the portfolio, ranked #743.

Berman Capital Advisors first reported a position in GH in Q4 2020 and has held it in 4 quarters since. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

  • Berman Capital Advisors held 340 shares of Guardant Health worth $42K as of Q3 2021.
  • Berman Capital Advisors bought 309 Guardant Health shares in Q3 2021, an estimated $36.7K.
  • Guardant Health made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #743 holding.
  • Berman Capital Advisors first reported a position in Guardant Health in Q4 2020 and has held it in 4 quarters since.
  • 374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.